MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Creativity related to dopaminergic treatment. A multicenter study

P.J. Garcia Ruiz, J.C. Martinez Castrillo, L. Vela (Madrid, Spain)

Meeting: 2016 International Congress

Abstract Number: 1868

Keywords: Dopamine agonists, Parkinsonism, Pramipexole, Ropinirole

Session Information

Date: Thursday, June 23, 2016

Session Title: Parkinson's disease: Clinical trials, pharmacology and treatment

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To study patients with Parkinson´s disease (PD) and enhanced creativity related to dopaminergic therapy.

Background: Impulse control disorders (ICD) including pathological gambling, hypersexuality, and compulsive shopping have been related with dopaminergic treatment especially dopamine agonists (DA). On the other hand, enhanced creativity, usually associated to artistic production, may emerge in patients with PD during dopaminergic therapy. ICD is very well recognized but enhanced creativity is under reported, probably because in contrast to ICD, enhanced creativity is usually (not always) positive and rarely disruptive for the patient and relatives.

Methods: We studied 21 patients (20 patients with PD and one patient with restless legs syndrome) with enhanced creativity, engaged in positive activities that began AFTER dopaminergic treatment (All but one patients were treated with DA including pramipexole 14/21; ropinirole 4/21 or rotigotine 2/21). Most PD patients (mean age: 66±14; evolution in years: 7.7 ± 3 years) had motor complications including motor fluctuations (14/20), dyskinesias (12/20) and freezing of gait (6/20).

Results: Most patients preferred painting as main activity, but many were engaged in several activities, usually in combination. Some patients began their artistic production after meeting with other subjects already engaged in artistic activities. Table 1 summarizes the main clinical data and activities.

CREATIVITY RELATED TO DOPAMINERGIC DRUGS
SUBJECT AGE /SEX YEARS MOTOR COMPL LD DOPAMINE AGONIST ACTIVITY
1 69/M 10 F GF D + (+R) ROP PAINTING, SCALE MODELS, WOODWORK
2 70/M 8 GF + (+R) PRM SCALE MODELS
3 74/M 10 F GF + PRM GARDENING
4 75/M 8 F + (+R) PRM PAINTING
5 67/F 3 – + (+R) PRM PAINTING, DANCE, THEATRE
6 53/F 5 D + (+E) – PAINTING
7 71/M 5 F D + (+R) ROT GARDENING
8 80/M 12 – + PRM CARVING, ENGRAVING
9 60/M 12 F + (+R) PRM SCALE MODELS
10 80/M 8 F GF + (+R) PRM PAINTING
11 82/F 10 – – PRM PAINTING
12 41/M 6 F D + PRM MUSIC
13 70/M 3 F D + (+R) ROP SCALE MODELS
14 47/F 5 F D + PRM TRINKETS, NECKLACES
15 75/M 3 – + PRM PAINTING
16 93/M 12 F D + ROT PAINTING
17 66/M 5 F D + PRM NAVIGATION CHARTS
18 75/M 11 F GF D + (+R) ROP PAINTING
19 42/M 7 F GF D + (+R E) PRM PAINTING
20 69/M 10 F D + ROP WRITING
21 43/M 9 F D + PRM PAINTING, WRITING, PHOTOGRAPHY
MOTOR COMP: MOTOR COMPLICATIONS; F: Fluctuationes; GF: Gait freezing; D: Dyskinesias; LD:Levodopa; ROP Ropinirole; PRM: Pramipexole; ROT: Rotigotine; R: Rasagiline; E: Entecapone“

Conclusions: Our hypothesis is that procuring a rich and stimulating environment to patients with PD may contribute to the appearance of this positive and under-reported phenomenon.

Presented in part at the annual Spanish Neurological Society Meeting (Valencia November 2015).

To cite this abstract in AMA style:

P.J. Garcia Ruiz, J.C. Martinez Castrillo, L. Vela. Creativity related to dopaminergic treatment. A multicenter study [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/creativity-related-to-dopaminergic-treatment-a-multicenter-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/creativity-related-to-dopaminergic-treatment-a-multicenter-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley